Emma Andrus, Editor

Recludix advances REX-8756, a first-in-class oral STAT6 inhibitor, showing promise for safer, targeted treatment of type 2 inflammatory skin diseases.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of June.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Learn more about the in-depth topics covered in the May 2025 print issue of Dermatology Times.

Dermatology Times is looking back on the top stories in dermatology from the month of May.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

A new partnership aims to revolutionize topical treatments for epidermolysis bullosa, enhancing patient care with innovative drug delivery technology.

Dermatology Times is recapping our exclusive expert interviews from the month of May.

This review of the latest dermatologic studies includes insights into psoriatic lesions and PsA, adipose mesenchymal stem cell-derived exosomes versus platelet-rich plasma, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

AI Medical Technology launches Dermalyser, an AI tool for melanoma diagnosis, enhancing detection accuracy and skin cancer care in Europe.

Answer our poll below.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

New research reveals significant racial disparities in depression risk among vitiligo patients, highlighting the need for culturally sensitive mental health support.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Celltrion's Yuflyma gains full FDA interchangeability, enhancing patient access and affordability for various inflammatory conditions.

A melanoma survivor shares her journey, emphasizing the importance of early detection and regular skin exams for skin cancer awareness.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Ascletis Pharma's investigational new drug application for ASC50 gains FDA clearance for a phase 1 trial for mild to moderate psoriasis.

Researchers reveal the resilience of Cutibacterium acnes in the skin microbiome post-laser treatments, suggesting its beneficial roles in skin health and aging.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Triveni Bio initiates a phase 1 trial for TRIV-509, a promising treatment for atopic dermatitis, targeting key inflammatory pathways.

This review of the latest dermatologic studies includes insights into chronic hand eczema, including self-reported severity, burden of pain and use of analgesics, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

New research explores how microgravity and cosmic radiation influence cancer cell behavior, immune responses, and potential advancements in oncology treatments.

A melanoma survivor shares her journey, emphasizing the importance of sun safety and regular skin exams to prevent skin cancer.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

The study offers reassurance regarding the safety profile of JAKis in patients with severe atopic dermatitis, particularly concerning their impact on venous thromboembolic events.